What Happens When The Dsp Gene Is Faulty? Key Facts

A faulty DSP gene disrupts a critical protein that acts like glue between skin and heart muscle cells. This can lead to serious health conditions, including a rare skin disorder and a form of heart disease that affects heart rhythm. The specific symptoms and risks depend heavily on the exact genetic change and how it is inherited.

What Does the DSP Gene Normally Do?

The DSP gene carries the instructions for making a protein called desmoplakin. This protein is a vital part of the “rivets” that hold cells together, known as desmosomes. Think of desmosomes as the structural welds between cells, particularly in tissues that experience a lot of physical stress.

Desmoplakin is found in high amounts in the skin and in the heart muscle. In the skin, it helps keep the outer layer attached to the layer underneath. In the heart, it helps connect heart muscle cells so they can work together as a single, coordinated pump. Without a properly functioning desmoplakin, these connections fail.

What Happens When the DSP Gene Is Faulty?

When the DSP gene has a pathogenic variant (a disease-causing mutation), the body cannot produce enough functional desmoplakin. This weakens the cellular glue in the skin and heart. The consequences are most often seen in two main areas: the skin and the heart.

In the heart, the weakened connections between muscle cells can lead to a condition called arrhythmogenic cardiomyopathy. This is a disease where heart muscle tissue is progressively replaced by fatty and fibrous scar tissue. This scarring disrupts the heart’s electrical signals, which can cause dangerous irregular heartbeats, known as arrhythmias. In some cases, this can lead to sudden cardiac arrest, especially in younger people and athletes.

On the skin, a faulty DSP gene can cause a rare condition called skin fragility-woolly hair syndrome. This condition is present from birth and is characterized by fragile skin that blisters and peels easily, often with minimal friction. It is also associated with unusually curly, woolly hair.

What Are the Symptoms of DSP-Related Heart Disease?

Symptoms of DSP-related heart disease often appear in early adulthood, but they can start at any age. Some people experience no symptoms at all for years. The most common symptoms include heart palpitations, which feel like a fluttering or racing heart, and episodes of lightheadedness or fainting, especially during exercise or strong emotion.

Other people may experience shortness of breath or swelling in the legs and ankles, which are signs of heart failure. It is important to note that the severity varies widely, even among members of the same family. Some research suggests that DSP-related heart disease may sometimes present with a sudden onset of chest pain and elevated cardiac enzymes, which can mimic a heart attack, even when the coronary arteries are clear.

What Are the Symptoms of DSP-Related Skin Fragility?

Skin fragility-woolly hair syndrome is a form of epidermolysis bullosa, a group of conditions that cause fragile skin. The skin symptoms are usually present at birth. The main sign is skin that blisters and erodes very easily, often on the hands, feet, elbows, and knees.

These blisters and erosions can be painful and may take time to heal. In addition to fragile skin, people with this condition typically have woolly hair from birth. They may also develop a condition called palmoplantar keratoderma, which is a thickening of the skin on the palms of the hands and soles of the feet. This thickening can be painful and may cause cracks in the skin.

How Is a Faulty DSP Gene Inherited?

The DSP gene can be inherited in two main ways: autosomal dominant and autosomal recessive. In autosomal dominant inheritance, a person only needs to inherit one faulty copy of the gene from one parent to develop the condition. In this case, there is often a family history of the condition, and heart problems are more common.

In autosomal recessive inheritance, a person must inherit two faulty copies of the gene, one from each parent. The parents typically carry one faulty copy each but do not have symptoms themselves. This form is often associated with the more severe skin symptoms and woolly hair.

Genetic testing is the only way to confirm which type of inheritance is involved. If a faulty DSP gene is identified in a family, relatives at risk should be offered genetic counseling and testing to understand their own risk.

How Is DSP-Related Heart Disease Diagnosed and Managed?

Diagnosis typically begins with a review of symptoms and family history. A doctor may order several tests to assess heart function. An electrocardiogram (ECG) checks the heart’s electrical activity. An echocardiogram uses sound waves to create images of the heart and can show structural changes. A cardiac MRI is often the most detailed test and can detect the fatty and fibrous scarring characteristic of this condition.

Management focuses on preventing dangerous arrhythmias and slowing the progression of heart failure. There is no cure, but treatments are available. Clinicians commonly prescribe medications called beta-blockers to help control heart rhythm and reduce the risk of arrhythmias.

For people at high risk of sudden cardiac arrest, an implantable cardioverter-defibrillator (ICD) may be recommended. This small device is placed under the skin and monitors the heart rhythm. If it detects a dangerous arrhythmia, it delivers a shock to restore a normal heartbeat. The decision to place an ICD is complex and is based on individual risk factors, including the specific genetic variant and results of heart imaging.

Lifestyle changes are also important. People with this condition are often advised to avoid intense or competitive exercise, as strenuous physical activity can trigger dangerous arrhythmias. The evidence clearly shows that high-intensity exercise increases risk in this population.

How Is DSP-Related Skin Fragility Managed?

Management of the skin condition is primarily supportive and focuses on preventing trauma and caring for wounds. This involves gentle handling of the skin, using soft clothing, and keeping the skin well-moisturized. Blisters should be drained carefully with a sterile needle to prevent them from spreading, and open wounds should be covered with non-adhesive dressings to promote healing and prevent infection.

There is no specific treatment to correct the underlying genetic problem. Care is aimed at managing symptoms and preventing complications like skin infections. Regular follow-up with a dermatologist who has experience with epidermolysis bullosa is essential.

What Are the Risks for Family Members?

Because DSP-related conditions are genetic, family members of an affected person may also be at risk. If a person has a confirmed pathogenic variant in the DSP gene, first-degree relatives—parents, siblings, and children—should be informed. They may benefit from genetic counseling and clinical screening for heart problems.

For relatives who are found to carry the faulty gene, regular cardiac monitoring is often recommended. This might include periodic ECGs and echocardiograms to detect early signs of heart disease before symptoms appear. Early detection allows for earlier intervention, which may reduce the risk of serious complications.

It is important to remember that not everyone who carries a faulty DSP gene will develop severe symptoms. The condition has what is called “variable expressivity,” meaning the severity can range from no symptoms at all to life-threatening complications, even within the same family.

What Is the Outlook for Someone With a Faulty DSP Gene?

The outlook varies significantly depending on the specific genetic variant and the severity of the condition. For those with the skin-predominant form, life expectancy is generally normal, though they must manage fragile skin throughout their lives. The primary concern for most people with a faulty DSP gene is the heart risk.

For those with heart involvement, the condition is progressive, meaning it tends to worsen over time. However, with proper medical management, including medication and possibly an ICD, many people live full lives. The most significant risk is sudden cardiac arrest, which is why identifying at-risk individuals early is so critical.

Ongoing research is exploring new treatments, including gene therapy, but these are not yet available in clinical practice. For now, the focus remains on accurate diagnosis, risk stratification, and proactive management of heart rhythm problems.